Related Targets |
Mechanism AT1R antagonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date15 May 2024 |
Mechanism AT1R antagonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. KR |
First Approval Date31 Jan 2013 |
Mechanism AT1R antagonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date20 Jan 2010 |
Start Date23 Sep 2024 |
Sponsor / Collaborator- |
Start Date04 Sep 2024 |
Sponsor / Collaborator- |
Start Date01 Sep 2024 |
Sponsor / Collaborator |